VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
Symptom Assessment
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Br J Cancer. 2021 01; 124(1):191-206.
View in:
PubMed
subject areas
Animals
Breast Neoplasms
Drug Resistance, Neoplasm
Estrogen Receptor alpha
Female
Humans
Mice
Mutation
Piperazines
Protein Kinase Inhibitors
Pyridines
Receptor Protein-Tyrosine Kinases
Signal Transduction
Xenograft Model Antitumor Assays
authors with profiles
CRISTIAN COARFA
SUZANNE FUQUA
SANDRA GRIMM